Cipesta™ DS

  • All Products
  • By Generic
  • By Therapeutic Segment

Cipesta™ DS

Therapeutic Segment: Antibiotic

Generic Name: Ciprofloxacin


In adults with:
• Lower respiratory tract infections due to Gram-negative bacteria: exacerbations of chronic obstructive pulmonary disease, broncho-pulmonary infections in cystic fibrosis or in bronchiectasis, pneumonia.
• Chronic suppurative otitis media.
• Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria
• Urinary tract infections
• Genital tract infections: gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae, epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae and pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae.
• Infections of the gastro intestinal tract (e.g. travellers’ diarrhea)
• Intra-abdominal infections
• Infections of the skin and soft tissue caused by Gram-negative bacteria
• Malignant external otitis
• Infections of the bones and joints
• Prophylaxis of invasive infections due to Neisseria meningitidis
• Inhalation anthrax (post-exposure prophylaxis and curative treatment)
• Typhoid fever caused by Salmonella typhi.
May be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.
Indicated in children and adolescents with:
• Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa
• Complicated urinary tract infections and pyelonephritis
• Inhalation anthrax (post-exposure prophylaxis and curative treatment)

Available as:

  • 400MG/100ML